ASSOCIATION BETWEEN GENOTYPE AND BASELINE HBsAg LEVELS AND THE HBsAg LEVELS AT HBeAg SEROCLEARANCE IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH ENTECAVIR

被引：0
|
作者：
Peng, C. -Y. [1 ]
Lai, H. -C. [1 ]
Su, W. -P. [1 ]
Lin, C. -H. [1 ]
Chuang, P. -H. [1 ]
Chen, S. -H. [1 ]
机构：
[1] China Med Univ Hosp, Dept Internal Med, Div Hepatogastroenterol, Taichung, Taiwan
来源：
JOURNAL OF HEPATOLOGY | 2014年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(14)61220-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1060
引用
收藏
页码：S430 / S430
页数：1
相关论文
共 50 条
  • [41] Comparison of HBsAg and HBeAg Levels with HBV DNA and ALT Levels in Patients with Chronic Hepatitis B Infections
    Saglik, Imran
    Mutlu, Derya
    Ongut, Gozde
    Guvenc, Hulya Iren
    Akbas, Halide
    Ogunc, Dilara
    Colak, Dilek
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2013, 19 (03): : 119 - 122
  • [42] Association of virological breakthrough and clinical outcomes in entecavir-treated HBeAg-positive chronic hepatitis B
    Huang, Yi-Jie
    Yang, Sheng-Shun
    Yeh, Hong-Zen
    Chang, Chi-Sen
    Peng, Yen-Chun
    PLOS ONE, 2019, 14 (08):
  • [43] Commentary: tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients
    Bradshaw, D.
    Danta, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (09) : 992 - 992
  • [44] A predictive scoring system for the seroclearance of HBsAg in HBeAg-seronegative chronic hepatitis B patients with genotype B or C infection
    Liu, Jessica
    Lee, Mei-Hsuan
    Batrla-Utermann, Richard
    Jen, Chin-Lan
    Iloeje, Uchenna H.
    Lu, Sheng-Nan
    Wang, Li-Yu
    You, San-Lin
    Hsiao, Chuhsing K.
    Yang, Hwai-I.
    Chen, Chien-Jen
    JOURNAL OF HEPATOLOGY, 2013, 58 (05) : 853 - 860
  • [45] ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis B
    Wong, Darren
    Littlejohn, Margaret
    Edwards, Rosalind
    Jackson, Kathy
    Revill, Peter
    Gaggar, Anuj
    Kitrinos, Kathryn
    Subramanian, Mani
    Marcellin, Patrick
    Buti-Ferret, Maria
    Janssen, Harry
    Gane, Ed
    Locarnini, Stephen
    Thompson, Alexander
    LIVER INTERNATIONAL, 2018, 38 (10) : 1760 - 1769
  • [46] THE IMPACT OF DECREASING LEVELS OF SERUM HBsAg ON HBsAg SEROCLEARANCE IN CHRONIC HEPATITIS B
    Nagaoka, S.
    Yatsuhashi, H.
    Kugiyama, Y.
    Bekki, S.
    Sasaki, R.
    Hashimoto, S.
    Ohtani, M.
    Bae, S. K.
    Saeki, A.
    Abiru, S.
    Komori, A.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S173 - S173
  • [47] Baseline HBsAg levels associated with HBsAg loss in HBeAg-negative chronic hepatitis B infection with persistently normal alanine aminotransferase
    Chen, Li
    Shi, Junjie
    Lu, Zhonghua
    Ye, Yun
    Zhou, Xinbei
    Tan, Youwen
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2019, 43 (03) : 310 - 316
  • [48] HBsAg and HBcrAg as predictors of HBeAg seroconversion in HBeAg-positive patients treated with nucleos(t)ide analogues
    Wang, B.
    Carey, I.
    Bruce, M.
    Montague, S.
    Dusheiko, G.
    Agarwal, K.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (08) : 886 - 893
  • [49] Early prediction of response to peginterferon for HBeAg-positive chronic hepatitis B using HBsAg levels at week 4 and week 8 of therapy
    Sonneveld, Milan J.
    Brouwer, Willem Pieter
    Zeuzem, Stefan
    Cakaloglu, Yilmaz
    Tabak, Fehmi
    Simon, Krzysztof
    Hansen, Bettina E.
    Janssen, Harry L.
    HEPATOLOGY, 2015, 62 : 1182A - 1182A
  • [50] Entecavir therapy for up to 96 weeks in patients with HBeAg-Positive chronic hepatitis B
    Gish, Robert G.
    Lok, Anna S.
    Chang, Ting-Tsung
    De Man, Robert A.
    Gadano, Adrian
    Sollano, Jose
    Han, Kwang-Hyub
    Chao, You-Chen
    Lee, Shou-Dong
    Harris, Melissa
    Yang, Joanna
    Colonno, Richard
    Brett-Smith, Helena
    GASTROENTEROLOGY, 2007, 133 (05) : 1437 - 1444
12345